Navigation Links
Bionovo Reports Third Quarter 2008 Financial Results
Date:11/3/2008

ionovo.com.

Forward Looking Statements

This release contains certain forward-looking statements relating to the business of Bionovo, Inc. that can be identified by the use of forward-looking terminology such as "believes," "expects," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, physician acceptance, third party reimbursement, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Bionovo, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Bionovo, Inc

(A Development Stage Company)

Condensed Statements of Operations

(Unaudited)

Three months ended Nine months ended

September 30, September 30,

2008 2007 2008 2007

Revenues $- $243,375 $- $250,875

Operating expenses:

Research and

development 3,941,303 2,444,674 8,881,340 7,212,445

General and

administrative 1,222,319 1,129,402 4
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
2. Bionovo Announces Proposed Public Offering of Common Stock
3. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
4. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
5. Bionovo Announces Third Quarter 2007 Financial Results
6. Bionovo to Present at Bank of Montreals 2007 Focus on Healthcare Conference
7. George Butler Joins Bionovos Board of Directors
8. Louis Drapeau Joins Bionovos Board of Directors
9. Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness
10. Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research
11. Bionovo Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... iLuv Creative Technology, the premier provider ... mobile lifestyle, announces they are now shipping MultiCharger-X, an ... iPad devices efficiently. Winner of the 2013 internationally recognized ... award, MultiCharger-X is revolutionizing the way businesses, schools, and ... , MultiCharger-X (iAD910) combines the best ...
(Date:5/22/2013)... , May 22, 2013   Oligomerix, Inc. ... of disease modifying therapeutics for Alzheimer,s disease (AD) ... of its Series B financing, which includes both ... that would represent approximately $2.8M in new investments ... investors supported the raise. Funding ...
(Date:5/22/2013)... NEW ORLEANS , May 22, 2013 ... of regenerative medicine, presented new data generated in collaboration ... (a leading health economics consultancy) demonstrating the significant healthcare ... and venous leg ulcers (VLU) place upon the US ... research, which reveal annual costs of up to $15 ...
(Date:5/22/2013)... Toronto, Ontario (PRWEB) May 22, 2013 ... of advanced sound therapy for tinnitus treatment. AudioNotch ... Destination Hearing . With clinic locations in both ... trusted provider of audiology and hearing services. AudioNotch's ... Zabell locations. , Upon entering a Destination Hearing ...
Breaking Biology Technology:iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2
... Germany, September 3 Hamburg is on,its way ... drug discovery, with,the northern German city,s town hall ... company that will run a state-of-the-art,drug discovery service ... of the German Federal Ministry of Education and ...
... Phase Results Show Positive Outcomes in Diabetic Patients, ... ,Boston Scientific Corporation (NYSE: BSX ) today ... phases of its TAXUS OLYMPIA,registry. The first 7,124 ... safety data on the TAXUS(R) Liberate(TM) coronary stent,system ...
... A vaccine against anthrax that is more effective and ... effective in tests in mice and guinea pigs, report University ... Infection and Immunity. , The scientists were able to ... the animals noses with a nanoemulsion a suspension of ...
Cached Biology Technology:European Centre for Modern Drug Discovery Established in Hamburg 2European Centre for Modern Drug Discovery Established in Hamburg 3European Centre for Modern Drug Discovery Established in Hamburg 4Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in World's Largest Stent Registry 2Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in World's Largest Stent Registry 3Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in World's Largest Stent Registry 4Anthrax vaccine produces immunity with nanoparticles, not needles 2Anthrax vaccine produces immunity with nanoparticles, not needles 3
(Date:5/21/2013)... scientists have charted the path of insulin action in ... a comprehensive blueprint for understanding what goes wrong in ... Humphrey and Professor David James from Sydney,s Garvan Institute ... online edition of the prestigious journal Cell Metabolism ... plays a very important role in the body because ...
(Date:5/21/2013)... modifications, which alter the way genes function without ... detected in the blood of pregnant women during ... foretell depression in the weeks after giving birth, ... debilitating. , The findings of the small study ... the journal Molecular Psychiatry . , "Postpartum ...
(Date:5/20/2013)... 2013) University of Minnesota Medical School researchers from ... with the University,s Brain Tumor Program, have developed a ... (MPNST) that allow them to discover new genes and ... research was published this week in the journal ... method, researchers in the lab of David Largaespada, Ph.D., ...
Breaking Biology News(10 mins):Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3U of M researchers develop model for better testing, targeting of MPNST 2
... WEST LAFAYETTE, Ind. - A Purdue University scientist ... a specialized mapping technique that could speed work in ... an organism,s observable characteristics. Using plants from 93 ... Gregor Mendel Institute of Plant Biology in Austria was ...
... Foundation (IOF) invites you to attend the first ... IOF Regionals: Asia-Pacific Osteoporosis Meeting, to be held ... your calendar: Online registration and abstract submission opens ... An exciting programme has been developed to provide ...
... the deep ocean floor support abundant populations of organisms, ... oxygen, according to an international study led by scientists ... global warming is likely to exacerbate oxygen depletion and ... The sunlit surface waters tend to be well ...
Cached Biology News:Genome mapping technique speeds process of finding specific genes 2Singapore program to provide clinical insight; showcase for regional research 2Seabed biodiversity in oxygen minimum zones 2Seabed biodiversity in oxygen minimum zones 3
... • Enzyme concentration - 5 units/µL ... in higher yields ,• Leaves an 'A' ... DNA polymerase which exhibits very high activity ... applications. To ensure the quality of the ...
Our original highly-purified, robust Taq Polymerase which delivers consistently high yields and minimal background...
... DNA Polymerase is the most thoroughly characterized ... testimony to its overall utility and efficacy. ... ideal for PCR applications. , It ... ,, AmpliTaq DNA Polymerase is a ...
... DNA Polymerase is a versatile and easy-to ... PCR applications. GCpro Taq DNA Polymerase is ... E. coli, containing the DNA polymerase I ... a highly processive 5'-3' DNA polymerase activity. ...
Biology Products: